Related Experiment Video
Updated: May 6, 2026
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
Neuronal dark matter: the emerging role of microRNAs in neurodegeneration
Emily F Goodall1, Paul R Heath, Oliver Bandmann
1Department of Neuroscience, Sheffield Institute for Translational Neuroscience, University of Sheffield Sheffield, UK.
Abstract:
MicroRNAs (miRNAs) are small, abundant RNA molecules that constitute part of the cell's non-coding RNA "dark matter." In recent years, the discovery of miRNAs has revolutionised the traditional view of gene expression and our understanding of miRNA biogenesis and function has expanded. Altered expression of miRNAs is increasingly recognized as a feature of many disease states, including neurodegeneration. Here, we review the emerging role for miRNA dysfunction in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS) and Huntington's disease pathogenesis. We emphasize the complex nature of gene regulatory networks and the need for systematic studies, with larger sample cohorts than have so far been reported, to reveal the most important miRNA regulators in disease. Finally, miRNA diversity and their potential to target multiple pathways, offers novel clinical applications for miRNAs as biomarkers and therapeutic agents in neurodegenerative diseases.
Insights
MicroRNA (miRNA) dysfunction is implicated in neurodegenerative diseases like Alzheimer's and Parkinson's. Further research is needed to understand miRNA roles and develop them as biomarkers and therapeutics.
Area of Science:
- Molecular Biology
- Neuroscience
- Genetics
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
- Altered miRNA expression is linked to various disease states, particularly neurodegeneration.
- Recent advancements have expanded understanding of miRNA biogenesis and function.
Purpose of the Study:
- To review the role of miRNA dysfunction in the pathogenesis of major neurodegenerative diseases.
- To highlight the complexity of miRNA-mediated gene regulatory networks in disease.
- To discuss the potential of miRNAs as biomarkers and therapeutic agents for neurodegenerative disorders.
Main Methods:
- Literature review of studies investigating miRNA involvement in neurodegenerative diseases.
- Analysis of current understanding of miRNA biogenesis and function.
- Synthesis of evidence linking miRNA dysregulation to Alzheimer's, Parkinson's, ALS, and Huntington's disease.
Main Results:
- miRNA dysfunction is an emerging hallmark of neurodegenerative diseases.
- Complex gene regulatory networks involve multiple miRNA regulators in disease pathogenesis.
- Studies with larger cohorts are necessary to identify key miRNA disease drivers.
Conclusions:
- miRNA dysregulation plays a significant role in the development of neurodegenerative diseases.
- miRNAs hold promise as novel biomarkers for early diagnosis and prognosis.
- The targeting capabilities of miRNAs offer potential for innovative therapeutic strategies in neurodegenerative conditions.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs
01:22MicroRNAs
01:37Neural Regulation